Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Astomin
2. At 17
3. D-3-methyl-n-methylmorphinan
4. Dastosin
5. Dimemorfan Phosphate
6. Dimemorfan Phosphate (1:1) Salt
7. Dimemorfan, (9alpha,13alpha,14alpha)-isomer
8. Dinemorphan
1. Dimemorfan [inn]
2. 3,17-dimethylmorphinan
3. 36309-01-0
4. 36304-82-2
5. (+)-3,17-dimethylmorphinan
6. 623oac38yu
7. Dimemorfane
8. Dimemorphan
9. Dimemorfano
10. Dimemorfanum
11. (1s,9s,10s)-4,17-dimethyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene
12. D-3-methyl-n-methylmorphinan
13. 3,n-dimethylmorphinan
14. N,3-dimethylmorphinan
15. At 17
16. Dimemorfane [inn-french]
17. Dimemorfanum [inn-latin]
18. Dimemorfano [inn-spanish]
19. Unii-623oac38yu
20. 3,n-dimethylmorphinan [iupac]
21. Einecs 252-963-3
22. Dimemorfan [mi]
23. Dimemorfan [who-dd]
24. Schembl499349
25. Chembl2106325
26. Chebi:135048
27. Dtxsid301043335
28. Zinc4215661
29. Db13810
30. Q5277240
31. Morphinan, 3,17-dimethyl-, (9alpha,13alpha,14alpha)-
| Molecular Weight | 255.4 g/mol |
|---|---|
| Molecular Formula | C18H25N |
| XLogP3 | 3.8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | 255.198699802 g/mol |
| Monoisotopic Mass | 255.198699802 g/mol |
| Topological Polar Surface Area | 3.2 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 352 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antitussive Agents
Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)
R - Respiratory system
R05 - Cough and cold preparations
R05D - Cough suppressants, excl. combinations with expectorants
R05DA - Opium alkaloids and derivatives
R05DA11 - Dimemorfan
Market Place
ABOUT THIS PAGE
A Dimemorfan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dimemorfan, including repackagers and relabelers. The FDA regulates Dimemorfan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dimemorfan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dimemorfan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dimemorfan supplier is an individual or a company that provides Dimemorfan active pharmaceutical ingredient (API) or Dimemorfan finished formulations upon request. The Dimemorfan suppliers may include Dimemorfan API manufacturers, exporters, distributors and traders.
click here to find a list of Dimemorfan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Dimemorfan Drug Master File in Japan (Dimemorfan JDMF) empowers Dimemorfan API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Dimemorfan JDMF during the approval evaluation for pharmaceutical products. At the time of Dimemorfan JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Dimemorfan suppliers with JDMF on PharmaCompass.
Dimemorfan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dimemorfan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dimemorfan GMP manufacturer or Dimemorfan GMP API supplier for your needs.
A Dimemorfan CoA (Certificate of Analysis) is a formal document that attests to Dimemorfan's compliance with Dimemorfan specifications and serves as a tool for batch-level quality control.
Dimemorfan CoA mostly includes findings from lab analyses of a specific batch. For each Dimemorfan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dimemorfan may be tested according to a variety of international standards, such as European Pharmacopoeia (Dimemorfan EP), Dimemorfan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dimemorfan USP).
LOOKING FOR A SUPPLIER?
